{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-037184","form_type":"8-K","ticker":"ADMA","cik":"0001368514","company_name":"ADMA BIOLOGICS, INC.","filed_at":"2024-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.802226+00:00","generated_at":"2026-05-31T09:16:33.744027+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"ADMA repays $30M of revolver; total debt reduced to $105M, a 22% reduction","bullets":["Repaid $30M from $72.5M Ares Capital revolver with no prepayment penalties.","Total gross debt reduced to $105M ($62.5M term loan + $42.5M revolver).","Paydown funded from cash on hand generated organically.","Lower interest expense expected to enhance earnings growth.","Company expects further reduction and optimization of capital costs."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-037184","json":"https://secwatch.observer/filing/0001140361-24-037184.json","markdown":"https://secwatch.observer/filing/0001140361-24-037184.md","text":"https://secwatch.observer/filing/0001140361-24-037184.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124037184/0001140361-24-037184-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124037184/ef20034127_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:16:33.744027+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}